Amador Bioscience Funding: $100M Raised, Series B (2021)
Amador Bioscience is based in Pleasanton, California. It has raised $100M in total funding. Latest round: Series B.
Amador Bioscience funding overview
Amador Bioscience is based in Pleasanton, California. Amador Bioscience has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in December 2021. The round record for Amador Bioscience runs through 2021; nothing later has been disclosed. Investors on record include Heyu Capital (MSA), Sequoia China, Hillhouse Ventures, Kaifeng Ventures, GL Ventures, Co-win Ventures. 6 distinct backers are named across the disclosed rounds.
Amador Bioscience has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Amador Bioscience?
Heyu Capital (MSA), Sequoia China, Hillhouse Ventures, Kaifeng Ventures, GL Ventures, Co-win Ventures are named among the investors backing Amador Bioscience.
What was the latest Amador Bioscience funding round?
The most recent disclosed round is a Series B, announced in December 2021.
Where is Amador Bioscience based?
Amador Bioscience is based in Pleasanton, California.
When did Amador Bioscience last raise?
The last disclosed Amador Bioscience round closed in December 2021 at Series B.
Amador Bioscience totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Pleasanton below to benchmark round size and investor mix.
